Journal profile · Medicine-Oncology

healthbook TIMES Oncology Hematology

ISSN 2673-2092 · eISSN 2673-2106 · THE HEALTHBOOK COMPANY LTD. · Switzerland

healthbook TIMES Oncology Hematology: diamond open access (no APC); no APC; review about 6 weeks (community reports); 26 articles in 2025; indexed in Scopus.

Impact factor—No published value
CAS zone—Not in the CAS Journal Ranking
CiteScore quartileQ4Hematology · rank 122/151 · 19th percentile
Review timeabout 6 weeksCommunity average
APCNo APCDiamond open access (no APC)
Acceptance—No reports yet
Articles per year262025 · OpenAlex count

Scope

Aims, scope and focus

healthbook TIMES Oncology Hematology is published by THE HEALTHBOOK COMPANY LTD.. By OpenAlex counts of its recent articles, its largest topics are Cancer Immunotherapy and Biomarkers, Lymphoma Diagnosis and Treatment and Breast Cancer Treatment Studies, together about 19.7% of its articles. Its main subfields are Oncology and Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)

Research area (LetPub): Medicine-Oncology

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Cancer Immunotherapy and BiomarkersMedicine7.2%
  2. Lymphoma Diagnosis and TreatmentMedicine6.4%
  3. Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology6.1%
  4. Lung Cancer Treatments and MutationsMedicine6.1%
  5. Multiple Myeloma Research and TreatmentsMedicine5.3%
  6. CAR-T cell therapy researchMedicine5.3%
  7. Chronic Lymphocytic Leukemia ResearchMedicine5%
  8. Lung Cancer Diagnosis and TreatmentMedicine4.2%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Not covered

Not covered by this edition.

CAS Xinrui Journal Ranking (March 2026)Not covered

Not covered by this edition.

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

CiteScore quartiles (Scopus, June 2026 release)

SubjectQuartileRankPercentile
HematologyQ4122/15119th
OncologyQ4352/42817th

Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub

Database indexing

ScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

CiteScore 2026-06
0.8LetPub ·
SJR 2026-06
0.16LetPub ·
SNIP 2026-06
0.08LetPub ·
h-index
4OpenAlex ·
i10-index
0OpenAlex ·
2-year mean citedness
0.33OpenAlex ·
Share of gold OA articles
0%LetPub ·

Articles by year OpenAlex count · 230 in total · the current year is incomplete

YearArticlesOpen accessCitations
2026191918
2025262628
2024434327
2023383814
2022363612
202136368

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average review time (community reports)
about 6 weeksLetPub ·
Submission to publication (journal-reported)
about 6 weeksDOAJ ·
Peer review
Single anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Diamond open access (no APC)DOAJ

Every article is open access and authors pay no article processing charge.

SourceAPCFee waiverLicenseObserved
DOAJNo APCNoCC BY-NC-SA
LetPubNo APCNo—

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
THE HEALTHBOOK COMPANY LTD.
Country or region
Switzerland
Language
English
ISSN
2673-2092
Electronic ISSN
2673-2106
Official links

FAQ

Frequently asked questions about healthbook TIMES Oncology Hematology

How long does peer review take at healthbook TIMES Oncology Hematology?

Authors report an average review time of about 6 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index healthbook TIMES Oncology Hematology?

According to LetPub and DOAJ records, healthbook TIMES Oncology Hematology is indexed in Scopus and DOAJ.

Is healthbook TIMES Oncology Hematology open access, and what is the APC?

healthbook TIMES Oncology Hematology is a diamond open-access journal (no APC). It charges no article processing charge.

Sources and updates

The facts on this page come from LetPub, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .